Positron emission tomography for benign and malignant disease

A Visioni, J Kim - Surgical Clinics, 2011 - surgical.theclinics.com
Imaging modalities play an important complimentary role to traditional history, physical
examination, and laboratory tests in the diagnosis and management of patient disease …

The yield of 18F-FDG PET/CT in patients with clinical stage IIA, IIB, or IIIA breast cancer: a prospective study

D Groheux, S Giacchetti, M Espié… - Journal of Nuclear …, 2011 - Soc Nuclear Med
The purpose of this study was to prospectively evaluate the role of 18F-FDG PET/CT in
patients with stage IIA, IIB, or IIIA breast cancer. Methods: During 56 mo, 131 consecutive …

FDG‐PET/CT compared with conventional imaging in the detection of distant metastases of primary breast cancer

N Niikura, CM Costelloe, JE Madewell… - The …, 2011 - academic.oup.com
Purpose. Evidence from studies with small numbers of patients indicates that 18F‐
fluorodeoxyglucose positron emission tomography/computed tomography (PET/CT) …

[PDF][PDF] Utility of 18FDG-PET/CT in breast cancer diagnostics–a systematic review

K Warning, MG Hildebrandt, B Kristensen, M Ewertz - Dan Med Bull, 2011 - ugeskriftet.dk
ABSTRACT 18F-fluorodeoxyglucose-positron emission tomography/computed tomography
(18FDG-PET/CT) is a non-invasive method for visualization of focally increased metabolism …

Comparison of FDG-PET/CT and bone scintigraphy for detection of bone metastases in breast cancer

S Hahn, T Heusner, S Kümmel, A Köninger… - Acta …, 2011 - journals.sagepub.com
Background Bone scintigraphy is the standard procedure for the detection of bone
metastases in breast cancer patients. FDG-PET/CT has been reported to be a sensitive tool …

Whole-body hybrid PET/MRI: ready for clinical use?

O Ratib, T Beyer - European journal of nuclear medicine and molecular …, 2011 - Springer
Since its introduction in 1998 [1], combined PET/CT has gained clinical acceptance as an
oncology imaging modality providing superior accuracy in tumour staging and assessment …

Diagnostic accuracy of fused positron emission tomography/magnetic resonance mammography: initial results

TA Heusner, S Hahn, C Jonkmanns… - The British Journal of …, 2011 - academic.oup.com
Objectives: The aim of this study was to evaluate the diagnostic accuracy of fused fluoro-
deoxy-d-glucose positron emission tomography/magnetic resonance mammography (FDG …

Initial staging impact of fluorodeoxyglucose positron emission tomography/computed tomography in locally advanced breast cancer

N Niikura, J Liu, CM Costelloe, SL Palla… - The …, 2011 - academic.oup.com
Purpose. Fluorodeoxyglucose positron emission tomography/computed tomography
(PET/CT) may reveal distant metastases more accurately than conventional imaging (CT …

PET/CT, Whole-Body MRI, and Whole-Body CT in the Diagnosis, Staging, and Follow-Up of Malignancy.

FL Carty, CP Shortt, MJ Shelly… - Journal of Surgical …, 2011 - search.ebscohost.com
OVERVIEW This article discusses the role of whole body imaging modalities in the
management of malignancy, comparing the use of PET/CT, whole-body MRI, and whole …

[引用][C] Meme kanserinin inisyal evrelemesinde FDG PET/BTnin uzak metastaz saptamasındaki yeri

A Aliyev - platform.almanhal.com
منصة المنهل لقد انتهت الجلسة. يرجى العمل على إعادة تحديث الصفحة إعادة تحديث يرجى الانتظار...
يتم تحضير الملف الاستخدام المجاني إذا كنت ترغب في الوصول الكامل إلى هذا المحتوى وقاعدة …